Leveraging Real-World Data in COVID-19 Response

References

• Abolghasemi, H., Eshghi, P., Cheraghali, A. M., Imani Fooladi, A. A., Bolouki Moghaddam, F., Imanizadeh, S., Moeini Maleki, M., Ranjkesh, M., Rezapour, M., Bahramifar, A., Einollahi, B., Hosseini, M. J., Jafari, N. J., Nikpouraghdam, M., Sadri, N., Tazik, M., Sali, S., Okati, S., Askari, E., Tabarsi, P., Aslani, J., Sharifipour, E., Jarahzadeh, M. H., Khodakarim, N., Salesi, M., Jafari, R., and Shahverdi, S. (2020), “Clinical Efficacy of Convalescent Plasma for Treatment of COVID-19 Infections: Results of a Multicenter Clinical Study,” Transfusion and Apheresis Science, 59, 102875. DOI: 10.1016/j.transci.2020.102875.
   PubMed Web of Science ®Google Scholar
• AHA COVID-19 CVD Registry (2021), available at https://www.heart.org/en/professional/quality-improvement/covid-19-cvd-registry. Accessed October 21, 2021.
   Google Scholar
• Anderson, R. M., Heesterbeek, H., Klinkenberg, D., and Hollingsworth, T. D. (2020), “How will Country-based Mitigation Measures Influence the Course of the COVID-19 Epidemic?” The Lancet, 395, 931–934. DOI: 10.1016/S0140-6736(20)30567-5.
   PubMed Web of Science ®Google Scholar
• Arshad, S., Kilgore, P., Chaudhry, Z. S., Jacobsen, G., Wang, D. D., Huitsing, K., Brar, I., Alangaden, G. J., Ramesh, M. S., McKinnon, J. E., O’Neill, W., Zervos, M., Nauriyal, V., Hamed, A. A., Nadeem, O., Swiderek, J., Godfrey, A., Jennings, J., Gardner-Gray, J., Ackerman, A. M., Lezotte, J., Ruhala, J., Fadel, R., Vahia, A., Gudipati, S., Parraga, T., Shallal, A., Maki, G., Tariq, Z., Suleyman, G., Yared, N., Herc, E., Williams, J., Lanfranco, O. A., Bhargava, P., and Reyes, K. (2020), “Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19,” International Journal of Infectious Diseases, 97, 396–403. DOI: 10.1016/j.ijid.2020.06.099.
   PubMed Web of Science ®Google Scholar
• ASCO Survey on COVID-19 in Oncology (ASCO) Registry (2021), available at https://www.asco.org/asco-coronavirus-information/coronavirus-registry. Accessed October 21, 2021.
   Google Scholar
• Balmford, B., Annan, J. D., Hargreaves, J. C., Altoè, M., and Bateman, I. J. (2020), “Cross-Country Comparisons of Covid-19: Policy, Politics and the Price of Life,” Environmental & Resource Economics, 76, 525–551.
   PubMed Web of Science ®Google Scholar
• Biran, N., Ip, A., Ahn, J., Go, R. C., Wang, S., Mathura, S., Sinclaire, B. A., Bednarz, U., Marafelias, M., Hansen, E., Siegel, D. S., Goy, A. H., Pecora, A. L., Sawczuk, I. S., Koniaris, L. S., Simwenyi, M., Varga, D. W., Tank, L. K., Stein, A. A., Allusson, V., Lin, G. S., Oser, W. F., Tuma, R. A., Reichman, J., Brusco, L., Carpenter, K. L., Costanzo, E. J., Vivona, V., and Goldberg, S. L. (2020), “Tocilizumab among Patients with COVID-19 in the Intensive Care Unit: A Multicentre Observational Study,” The Lancet. Rheumatology, 2, e603–e612. DOI: 10.1016/S2665-9913(20)30277-0.
   PubMedGoogle Scholar
• Blonde, L., Khunti, K., Harris, S. B., Meizinger, C., and Skolnik, N. S. (2018), “Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician,” Advances in Therapy, 35, 1763–1774. DOI: 10.1007/s12325-018-0805-y.
   PubMed Web of Science ®Google Scholar
• Bol, D., Giani, M., Blais, A., and Loewen, P. J. (2020), “The Effect of COVID-19 Lockdowns on Political Support: Some Good News for Democracy?,” European Journal of Political Research, 60, 497–505. DOI: 10.1111/1475-6765.12401.
   Web of Science ®Google Scholar
• Boulware, D. R., Pullen, M. F., Bangdiwala, A. S., Pastick, K. A., Lofgren, S. M., Okafor, E. C., Skipper, C. P., Nascene, A. A., Nicol, M. R., Abassi, M., Engen, N. W., Cheng, M. P., LaBar, D., Lother, S. A., MacKenzie, L. J., Drobot, G., Marten, N., Zarychanski, R., Kelly, L. E., Schwartz, I. S., McDonald, E. G., Rajasingham, R., Lee, T. C., and Hullsiek, K. H. (2020), “A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19,” The New England Journal of Medicine, 383, 517–525. DOI: 10.1056/NEJMoa2016638.
   PubMed Web of Science ®Google Scholar
• Carnegie Mellon University COVIDcast (2021), available at https://delphi.cmu.edu/covidcast/. Accessed October 21, 2021.
   Google Scholar
• Carnegie Mellon University Delphi Epidata API (2021), available at https://cmu-delphi.github.io/delphi-epidata/api/covidcast/textunderscoresignals.html. Accessed October 21, 2021.
   Google Scholar
• Carnegie Mellon University DELPHI (2021), available at https://delphi.cmu.edu/. Accessed October 21, 2021.
   Google Scholar
• Cavalcanti, A. B., Zampieri, F. G., Rosa, R. G., Azevedo, L. C. P., Veiga, V. C., Avezum, A., Damiani, L. P., Marcadenti, A., Kawano-Dourado, L., Lisboa, T., Junqueira, D. L. M., de Barros E Silva, P. G. M., Tramujas, L., Abreu-Silva, E. O., Laranjeira, L. N., Soares, A. T., Echenique, L. S., Pereira, A. J., Freitas, F. G. R., Gebara, O. C. E., Dantas, V. C. S., Furtado, R. H. M., Milan, E. P., Golin, N. A., Cardoso, F. F., Maia, I. S., Hoffmann Filho, C. R., Kormann, A. P. M., Amazonas, R. B., Bocchi de Oliveira, M. F., Serpa-Neto, A., Falavigna, M., Lopes, R. D., Machado, F. R., Berwanger, O., and Coalition Covid-19 Brazil I Investigators. (2020), “Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19,” The New England Journal of Medicine, 383, 2041–2052. Erratum in: The New England Journal of Medicine, 2020 Nov 19;383(21):e119.
   PubMed Web of Science ®Google Scholar
• CDC COVID-NET. (2021), Available at: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covid-net/purpose-methods.html. Accessed October 21, 2021.
   Google Scholar
• Centers for Disease Control and Prevention (2021), “COVID-19 Mathematical Modeling,” available at https://www.cdc.gov/coronavirus/2019-ncov/covid-data/mathematical-modeling.html. Accessed October 2021.
   Google Scholar
• Chaudhuri, S., Lo, A. W., Xiao, D., and Xu, Q. (2020), “Bayesian Adaptive Clinical Trials for Anti-Infective Therapeutics during Epidemic Outbreaks,” Harvard Data Science Review, Special Issue 1. DOI: 10.1162/99608f92.7656c213..
   Google Scholar
• Chen, M., Fan, Y., Wu, X., Zhang, L., Guo, T., Deng, K., Gao, J., Luo, H., He, T., Gong, Y., Wang, H., Wan, J., Wang, X., and Lu, Z. (2020), “Clinical Characteristics And Risk Factors For Fatal Outcome in Patients With 2019-Coronavirus Infected Disease (COVID-19) in Wuhan, China,” Lancet. DOI: 10.2139/ssrn.3546069..
   Google Scholar
• Chen, J., Ho, M., Lee, K., Song, Y., Fang, Y., Goldstein, B. A., He, W., Irony, T., Jiang, Q., van der Laan, M., Lee, H., Lin, X., Meng, Z., Mishra-Kalyani, P., Rockhold, F., Wang, H., and White, R. (2021), “The Current Landscape in Biostatistics of Real-World Data and Evidence: Clinical Study Design and Analysis,” Statistics in Biopharmaceutical Research, 1–4. DOI: 10.1080/19466315.2021.1883474.
   Web of Science ®Google Scholar
• ClinicalTrials.gov Adaptive COVID-19 Treatment Trial 4 (ACTT-4) (2021), available at https://clinicaltrials.gov/ct2/show/NCT04640168. Accessed October 21, 2021.
   Google Scholar
• Collins, R., Bowman, L., Landray, M., and Peto, R. (2020), “The Magic of Randomization versus the Myth of Real-World Evidence,” The New England Journal of Medicine, 382, 674–678. DOI: 10.1056/NEJMsb1901642.
   PubMed Web of Science ®Google Scholar
• Cook, J. A., Julious, S. A., Sones, W., Rothwell, J. C., Ramsay, C. R., Hampson, L. V., Emsley, R., Walters, S. J., Hewitt, C., Bland, M., Fergusson, D. A., Berlin, J. A., Altman, D., and Vale, L. D. (2017), “Choosing the Target Difference (‘effect size’) for a Randomised Controlled Trial – DELTA2 Guidance Protocol,” Trials, 18, 271. DOI: 10.1186/s13063-017-1969-5.
   PubMedGoogle Scholar
• COVID-19 Evidence Accelerator (2021), available at https://friendsofcancerresearch.org/covid19. Accessed October 21, 2021.
   Google Scholar
• COVID-19 Forecast Hub (2021), available at https://covid19forecasthub.org/. Accessed October 21, 2021.
   Google Scholar
• COVID-19 Predictions (2021), available at https://yumouqiu.shinyapps.io/covid-predict/. Accessed October 21, 2021.
   Google Scholar
• COVID-19 RISK and Treatments (CORIST) Collaboration (2020), “Use of Hydroxychloroquine in Hospitalised COVID-19 Patients is Associated with Reduced Mortality: Findings from the Observational Multicentre Italian CORIST Study,” European Journal of Internal Medicine, 82, 38–47.
   PubMed Web of Science ®Google Scholar
• Dickerman, B. A., García-Albéniz, X., Logan, R. W., Denaxas, S., and Hernán, M. A. (2019), “Avoidable Flaws in Observational Analyses: An Application to Statins and Cancer,” Nature Medicine, 25, 1601–1606. DOI: 10.1038/s41591-019-0597-x.
   PubMed Web of Science ®Google Scholar
• Discovery VIRUS COVID-19 Registry (2021), available at https://www.sccm.org/Research/Research/Discovery-Research-Network/VIRUS-COVID-19-Registry. Accessed October 21, 2021.
   Google Scholar
• Dodd, L. E., Follmann, D., Wang, J., Koenig, F., Korn, L. L., Schoergenhofer, C., Proschan, M., Hunsberger, S., Bonnett, T., Makowski, M., Belhadi, D., Wang, Y., Cao, B., Mentre, F., and Jaki, T. (2020), “Endpoints for Randomized Controlled Clinical Trials for COVID-19 Treatments,” Clinical Trials (London, England), 17, 472–482. DOI: 10.1177/1740774520939938.
   PubMed Web of Science ®Google Scholar
• Duan, K., Liu, B., Li, C., Zhang, H., Yu, T., Qu, J., Zhou, M., Chen, L., Meng, S., Hu, Y., Peng, C., Yuan, M., Huang, J., Wang, Z., Yu, J., Gao, X., Wang, D., Yu, X., Li, L., Zhang, J., Wu, X., Li, B., Xu, Y., Chen, W., Peng, Y., Hu, Y., Lin, L., Liu, X., Huang, S., Zhou, Z., Zhang, L., Wang, Y., Zhang, Z., Deng, K., Xia, Z., Gong, Q., Zhang, W., Zheng, X., Liu, Y., Yang, H., Zhou, D., Yu, D., Hou, J., Shi, Z., Chen, S., Chen, Z., Zhang, X., and Yang, X. (2020), “Effectiveness of Convalescent Plasma Therapy in Severe COVID-19 Patients,” Proceedings of the National Academy of Sciences of the United States of America, 117, 9490–9496. DOI: 10.1073/pnas.2004168117.
   PubMed Web of Science ®Google Scholar
• Eichler, H.-G., Koenig, F., Arlett, P., Enzmann, H., Humphreys, A., Pétavy, F., Schwarzer-Daum, B., Sepodes, B., Vamvakas, S., and Rasi, G. (2020), “Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation,” Clinical Pharmacology and Therapeutics, 107, 773–779. DOI: 10.1002/cpt.1638.
   PubMed Web of Science ®Google Scholar
• Ezzat, V. A., Lee, V., Ahsan, S., Chow, A. W., Segal, O., Rowland, E., Lowe, M. D., and Lambiase, P. D. (2015), “A Systematic Review of ICD Complications in Randomised Controlled Trials Versus Registries: Is Our ‘Real-WORLD’DATA an Underestimation?,” Open Heart, 2, e000198. DOI: 10.1136/openhrt-2014-000198.
   PubMed Web of Science ®Google Scholar
• FDA News & Events for Human Drugs (2020), “Real World Evidence – From Safety to a Potential Tool for Advancing Innovative Ways to Develop New Medical Therapies,” available at https://www.fda.gov/drugs/news-events-human-drugs/real-world-evidence-safety-potential-tool-advancing-innovative-ways-develop-new-medical-therapies. Content current as of: 24 Feb 2020.
   Google Scholar
• Firth, J. A., Hellewell, J., Klepac, P., Kissler, S., Kucharski, A. J., Spurgin, L. G., and CMMID COVID-19 Working Group. (2020), “Using a Real-World Network to Model Localized COVID-19 Control Strategies,” Nature Medicine, 26, 1616–1622. DOI: 10.1038/s41591-020-1036-8.
   PubMed Web of Science ®Google Scholar
• Franchetti, Y. (2022), “Use of Propensity Scoring and Its Application to Real-World Data: Advantages, Disadvantages, and Methodological Objectives Explained to Researchers Without Using Mathematical Equations,” Journal of Clinical Pharmacology, 62, 304–319. DOI: 10.1002/jcph.1989.
   PubMed Web of Science ®Google Scholar
• Gao, J., Tian, Z., and Yang, X. (2020), “Breakthrough: Chloroquine Phosphate has shown Apparent Efficacy in Treatment of COVID-19 Associated Pneumonia in Clinical Studies,” Bioscience Trends, 14, 72–73. DOI: 10.5582/bst.2020.01047.
   PubMed Web of Science ®Google Scholar
• Gautret, P., Lagier, J.-C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., Tissot Dupont, H., Honoré, S., Colson, P., Chabrière, E., La Scola, B., Rolain, J.-M., Brouqui, P., and Raoult, D. (2020), “Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-randomized Clinical Trial,” International Journal of Antimicrobial Agents., 56, 105949. DOI: 10.1016/j.ijantimicag.2020.105949.
   PubMed Web of Science ®Google Scholar
• Geleris, J., Sun, Y., Platt, J., Zucker, J., Baldwin, M., Hripcsak, G., Labella, A., Manson, D. K., Kubin, C., Barr, R. G., Sobieszczyk, M. E., and Schluger, N. W. (2020), “Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19,” The New England Journal of Medicine, 382, 2411–2418. DOI: 10.1056/NEJMoa2012410.
   PubMed Web of Science ®Google Scholar
• Ghadessi, M., Tang, R., Zhou, J., Liu, R., Wang, C., Toyoizumi, K., Mei, C., Zhang, L., Deng, C. Q., and Beckman, R. A. (2020), “A Roadmap to using Historical Controls in Clinical Trials–by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG),” Orphanet Journal of Rare Diseases, 15, 1–9. DOI: 10.1186/s13023-020-1332-x.
   PubMed Web of Science ®Google Scholar
• Gökbuget, N., Kelsh, M., Chia, V., Advani, A., Bassan, R., Dombret, H., Doubek, M., Fielding, A. K., Giebel, S., Haddad, V., Hoelzer, D., Holland, C., Ifrah, N., Katz, A., Maniar, T., Martinelli, G., Morgades, M., O’Brien, S., Ribera, J.-M., Rowe, J. M., Stein, A., Topp, M., Wadleigh, M., and Kantarjian, H. (2016), “Blinatumomab vs Historical Standard Therapy of Adult Relapsed/Refractory Acute Lymphoblastic Leukemia,” Blood Cancer Journal, 6, e473. DOI: 10.1038/bcj.2016.84.
   PubMed Web of Science ®Google Scholar
• Goldberg, M. H., Gustafson, A., Maibach, E. W., Ballew, M. T., Bergquist, P., Kotcher, J. E., Marlon, J. R., Rosenthal, S. A., and Leiserowitz, A. (2020), “Mask-Wearing Increased after a Government Recommendation: A Natural Experiment in the US during the COVID-19 Pandemic,” Frontiers in Communication, 5, 44. DOI: 10.3389/fcomm.2020.00044.
   Google Scholar
• Government of India (2021), “State/UT wise Aadhaar Saturation: 15th January 2020,” available at https://uidai.gov.in/images/state-wise-aadhaar-saturation.pdf. Accessed October 21, 2021.
   Google Scholar
• Goyal, P., Choi, J. J., Pinheiro, L. C., Schenck, E. J., Chen, R., Jabri, A., Satlin, M. J., Campion, T. R., Nahid, M., Ringel, J. B., Hoffman, K. L., Alshak, M. N., Li, H. A., Wehmeyer, G. T., Rajan, M., Reshetnyak, E., Hupert, N., Horn, E. M., Martinez, F. J., Gulick, R. M., and Safford, M. M. (2020), “Clinical Characteristics of Covid-19 in New York City,” The New England Journal of Medicine, 382, 2372–2374. DOI: 10.1056/NEJMc2010419.
   PubMed Web of Science ®Google Scholar
• Gu, J., Yan, H., Huang, Y., Zhu, Y., Sun, H., Zhang, X., Wang, Y., Qiu, Y., and Chen, X. (2020), “Better Strategies for Containing COVID-19 Epidemics – A Study of 25 Countries via an Extended Varying Coefficient SEIR Model,” MedRxiv. DOI: 10.1101/2020.04.27.20081232..
   Google Scholar
• Hainmueller, J., and Xu, Y. (2013), “A Stata Package for Entropy Balancing,” Journal of Statistical Software, 54, 1–18. DOI: 10.18637/jss.v054.i07.
   Web of Science ®Google Scholar
• Hale, T., Angrist, N., Boby, T., Cameron-Blake, E., Hallas, L., and Kira, B. (2020), “Variation in Government Responses to COVID-19” Version 10.0. Blavatnik School of Government Working Paper. available at https://www.bsg.ox.ac.uk/sites/default/files/2020-12/BSG-WP-2020-032-v10.pdf. Accessed 21 OCT 2021.
   Google Scholar
• Hao, X., Cheng, S., Wu, D., Wu, T., Lin, X., and Wang, C. (2020), “Reconstruction of the Full Transmission Dynamics of COVID-19 in Wuhan,” Nature, 584, 420–424. DOI: 10.1038/s41586-020-2554-8.
   PubMed Web of Science ®Google Scholar
• He, X., Lau, E. H. Y., Wu, P., Deng, X., Wang, J., Hao, X., Lau, Y. C., Wong, J. Y., Guan, Y., Tan, X., Mo, X., Chen, Y., Liao, B., Chen, W., Hu, F., Zhang, Q., Zhong, M., Wu, Y., Zhao, L., Zhang, F., Cowling, B. J., Li, F., and Leung, G. M. (2020), “Temporal Dynamics in Viral Shedding and Transmissibility of COVID-19,” Nature Medicine, 26, 672–675. DOI: 10.1038/s41591-020-0869-5.
   PubMed Web of Science ®Google Scholar
• Ho, M., van der Laan, M., Lee, H., Chen, J., Lee, K., Fang, Y., He, W., Irony, T., Jiang, Q., Lin, X., Meng, Z. (2021), “The Current Landscape in Biostatistics of Real-World Data and Evidence: Causal Inference Frameworks for Study Design and Analysis,” Statistics in Biopharmaceutical Research, 12, 1–4. DOI: 10.1080/19466315.2021.1883475.
   Google Scholar
• International Institute for Population Sciences (2021), “National Family Health Survey,” available at http://rchiips.org/NFHS/nfhs4.shtml. Accessed October 21, 2021.
   Google Scholar
• ISU and PKU Model: Collaborative team of Iowa State and Peking University – ISUandPKU-vSEIdR (2021), available at https://zoltardata.com/model/268. Accessed October 21, 2021.
   Google Scholar
• JHU Johns Hopkins Coronavirus Resource Center (2021), available at https://coronavirus.jhu.edu/. Accessed October 21, 2021.
   Google Scholar
• John, M., and Shaiba, H. (2019), “Main Factors Influencing Recovery in MERS Co-V Patients using Machine Learning,” Journal of Infection and Public Health, 12, 700–704. DOI: 10.1016/j.jiph.2019.03.020.
   PubMed Web of Science ®Google Scholar
• Joyner, M. J., Klassen, S. A., Senefeld, J., Johnson, P. W., Carter, R. E., and Wiggins, C. C. (2020a), “Evidence Favouring the Efficacy of Convalescent Plasma for COVID-19 Therapy,” medRxiv, 20162917.
   Google Scholar
• Joyner, M. J., Senefeld, J. W., Klassen, S. A., Mills, J. R., Johnson, P. W., and Theel, E. S. (2020b), “Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience,” medRxiv, 20169359.
   Google Scholar
• Joyner, M. J., Wright, R. S., Fairweather, D., Senefeld, J. W., Bruno, K. A., Klassen, S. A., Carter, R. E., Klompas, A. M., Wiggins, C. C., Shepherd, J. R. A., Rea, R. F., Whelan, E. R., Clayburn, A. J., Spiegel, M. R., Johnson, P. W., Lesser, E. R., Baker, S. E., Larson, K. F., Ripoll, J. G., Andersen, K. J., Hodge, D. O., Kunze, K. L., Buras, M. R., Vogt, M. N. P., Herasevich, V., Dennis, J. J., Regimbal, R. J., Bauer, P. R., Blair, J. E., Van Buskirk, C. M., Winters, J. L., Stubbs, J. R., Paneth, N. S., Verdun, N. C., Marks, P., and Casadevall, A. (2020c), “Early Safety Indicators of COVID-19 Convalescent Plasma in 5000 Patients,” Journal of Clinical Investigation, 130, 4791–4797. DOI: 10.1172/JCI140200.
   PubMed Web of Science ®Google Scholar
• Joyner, M. J., Carter, R. E., Senefeld, J. W., Klassen, S. A., Mills, J. R., Johnson, P. W., Theel, E. S., Wiggins, C. C., Bruno, K. A., Klompas, A. M., Lesser, E. R., Kunze, K. L., Sexton, M. A., Diaz Soto, J. C., Baker, S. E., Shepherd, J. R. A., van Helmond, N., Verdun, N. C., Marks, P., van Buskirk, C. M., Winters, J. L., Stubbs, J. R., Rea, R. F., Hodge, D. O., Herasevich, V., Whelan, E. R., Clayburn, A. J., Larson, K. F., Ripoll, J. G., Andersen, K. J., Buras, M. R., Vogt, M. N. P., Dennis, J. J., Regimbal, R. J., Bauer, P. R., Blair, J. E., Paneth, N. S., Fairweather, D., Wright, R. S., and Casadevall, A. (2021), “Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19,” The New England Journal of Medicine, 384, 1015–1027. DOI: 10.1056/NEJMoa2031893.
   PubMed Web of Science ®Google Scholar
• Kenji, M., Katsushi, K., Alexander, Z., and Gerardo, C. (2020), “Estimating the Asymptomatic Proportion of Coronavirus Disease 2019 (COVID-19) Cases on Board the Diamond Princess Cruise Ship, Yokohama, Japan, 2020,” Eurosurveillance, 25, pii =2000180.
   Web of Science ®Google Scholar
• Kraemer, M. U. G., Yang, C.-H., Gutierrez, B., Wu, C.-H., Klein, B., Pigott, D. M., Du Plessis, L., Faria, N. R., Li, R., Hanage, W. P., Brownstein, J. S., Layan, M., Vespignani, A., Tian, H., Dye, C., Pybus, O. G., Scarpino, S. V., and Open COVID-19 Data Working Group. (2020), “The Effect of Human Mobility and Control Measures on the COVID-19 Epidemic in China,” Science, 368, 493–497. DOI: 10.1126/science.abb4218.
   PubMed Web of Science ®Google Scholar
• Levenson, M., He, W., Chen, J., Fang, Y., Faries, D., Goldstein, B. A., Ho, M., Lee, K., Mishra-Kalyani, P., Rockhold, F., Wang, H., and Zink, R. C. (2021), “Biostatistical Considerations When using RWD and RWE in Clinical Studies for Regulatory Purposes: A Landscape Assessment,” Statistics in Biopharmaceutical Research, 9, 1–1. DOI: 10.1080/19466315.2021.1883473.
   Google Scholar
• Lin, J., Gamalo-Siebers, M., and Tiwari, R. (2018), “Propensity Score Matched Augmented Controls in Randomized Clinical Trials: A Case Study,” Pharmaceutical Statistics, 17, 629–647. DOI: 10.1002/pst.1879.
   PubMed Web of Science ®Google Scholar
• Lin, J., Gamalo-Siebers, M., and Tiwari, R. (2019), “Propensity-Score-Based Priors for Bayesian Augmented Control Design,” Pharmaceutical Statistics, 18, 223–238. DOI: 10.1002/pst.1918.
   PubMed Web of Science ®Google Scholar
• Lippi, G., Plebani, M., and Henry, B. M. (2020), “Thrombocytopenia is Associated with Severe Coronavirus Disease 2019 (COVID-19) Infections: A Meta-Analysis,” Clinica Chimica Acta, 506, 145–148. DOI: 10.1016/j.cca.2020.03.022.
   PubMed Web of Science ®Google Scholar
• Liu, S., Luo, H., Wang, Y., Wang, D., Ju, S., and Yang, Y. (2020), “Characteristics and Associations with Severity in COVID-19 Patients: A Multicentre Cohort Study from Jiangsu Province, China,” SSRN. DOI: 10.2139/ssrn.3548753.
   Google Scholar
• Madigan, D., Ryan, P. B., Schuemie, M., Stang, P. E., Overhage, J. M., Hartzema, A. G., Suchard, M. A., DuMouchel, W., and Berlin, J. A. (2013), “Evaluating the Impact of Database Heterogeneity on Observational Study Results,” American Journal of Epidemiology, 178, 645–651. DOI: 10.1093/aje/kwt010.
   PubMed Web of Science ®Google Scholar
• Martina, R., Jenkins, D., Bujkiewicz, S., Dequen, P., and Abrams, K., on Behalf of Get Real Workpage (2018), “The Inclusion of Real World Evidence in Clinical Development Planning,” Trials, 19, 468. DOI: 10.1186/s13063-018-2769-2.
   PubMed Web of Science ®Google Scholar
• Menni, C., Valdes, A. M., Freidin, M. B., Sudre, C. H., Nguyen, L. H., Drew, D. A., Ganesh, S., Varsavsky, T., Cardoso, M. J., El-Sayed Moustafa, J. S., Visconti, A., Hysi, P., Bowyer, R. C. E., Mangino, M., Falchi, M., Wolf, J., Ourselin, S., Chan, A. T., Steves, C. J., and Spector, T. D. (2020a), “Real-Time Tracking of Self-Reported Symptoms to Predict Potential COVID-19,” Nature Medicine, 26, 1037–1034. DOI: 10.1038/s41591-020-0916-2.
   PubMed Web of Science ®Google Scholar
• Menni, C., Valdes, A., Freydin, M. B., Ganesh, S., Moustafa, J. E.-S., Visconti, A., Hysi, P., Bowyer, R. C. E., Mangino, M., Falchi, M., Wolf, J., Steves, C. J., and Spector, T. D. (2020b), “Loss of Smell and Taste in Combination with other Symptoms is a Strong Predictor of COVID-19 Infection,” Nature Medicine, 26, 1037–1040.
   PubMed Web of Science ®Google Scholar
• National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Drug Discovery, Development, and Translation, Shore, C., and Gee, A. W. eds. (2019), Examining the Impact of Real-World Evidence on Medical Product Development: Proceedings of a Workshop Series. Washington (DC): National Academies Press (US). February 6, 2019, Barriers and Disincentives to the Use of Real-World Evidence and Real-World Data. available at https://www.ncbi.nlm.nih.gov/books/NBK540112/. Accessed October 21, 2021.
   Google Scholar
• NIH-COVID-19 Treatment Guidelines (2020), “Chloroquine or Hydroxychloroquine With or Without Azithromycin,” October 9, 2020. available at https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/chloroquine-or-hydroxychloroquine-with-or-without-azithromycin/. Accessed October 21, 2021.
   Google Scholar
• Ooi, S. T., Parthasarathy, P., Lin, Y., Nallakaruppan, V., Ng, S., and Tan, T. C. (2020), “Adjunctive Corticosteroids for COVID-19: A Retrospective Cohort Study,” MedRxiv. DOI: 10.1101/2020.07.18.20157008..Accessed October 21, 2021.
   Google Scholar
• Oxford COVID-19 Government Response Tracker (2021), “Blavatnik School of Government.” Available at: https://www.bsg.ox.ac.uk/research/research-projects/covid-19-government-response-tracker. Accessed October 21, 2021.
   Google Scholar
• PIDTRAN Pediatric COVID-19 Case Registry (2021), available at https://www.pedscovid19registry.com/. Accessed October 21, 2021.
   Google Scholar
• Rosenberg, E. S., Dufort, E. M., Udo, T., Wilberschied, L. A., Kumar, J., Tesoriero, J., Weinberg, P., Kirkwood, J., Muse, A., DeHovitz, J., Blog, D. S., Hutton, B., Holtgrave, D. R., and Zucker, H. A. (2020), “Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State,” JAMA, 323, 2493–2502. DOI: 10.1001/jama.2020.8630.
   PubMed Web of Science ®Google Scholar
• Rudrapatna, V. A., and Butte, A. J. (2020), “Opportunities and Challenges in Using Real-World Data for Health Care,” The Journal of Clinical Investigation, 130, 565–574. DOI: 10.1172/JCI129197.
   PubMed Web of Science ®Google Scholar
• Seifu, Y., Gamalo-Siebers, M., Barthel, F. M.-S., Lin, J., Qiu, J., Cooner, F., Ruan, S., and Walley, R. (2020), “Real-World Evidence Utilization in Clinical Development Reflected by US Product Labeling: Statistical Review,” Therapeutic Innovation & Regulatory Science, 54, 1436–1443.
   PubMed Web of Science ®Google Scholar
• Self, W. H., Semler, M. W., Leither, L. M., Casey, J. D., Angus, D. C., Brower, R. G., Chang, S. Y., Collins, S. P., Eppensteiner, J. C., Filbin, M. R., Files, D. C., Gibbs, K. W., Ginde, A. A., Gong, M. N., Harrell, F. E., Hayden, D. L., Hough, C. L., Johnson, N. J., Khan, A., Lindsell, C. J., Matthay, M. A., Moss, M., Park, P. K., Rice, T. W., Robinson, B. R. H., Schoenfeld, D. A., Shapiro, N. I., Steingrub, J. S., Ulysse, C. A., Weissman, A., Yealy, D. M., Thompson, B. T., Brown, S. M., Steingrub, J., Smithline, H., Tiru, B., Tidswell, M., Kozikowski, L., Thornton-Thompson, S., De Souza, L., Hou, P., Baron, R., Massaro, A., Aisiku, I., Fredenburgh, L., Seethala, R., Johnsky, L., Riker, R., Seder, D., May, T., Baumann, M., Eldridge, A., Lord, C., Shapiro, N., Talmor, D., O’Mara, T., Kirk, C., Harrison, K., Kurt, L., Schermerhorn, M., Banner-Goodspeed, V., Boyle, K., Dubosh, N., Filbin, M., Hibbert, K., Parry, B., Lavin-Parsons, K., Pulido, N., Lilley, B., Lodenstein, C., Margolin, J., Brait, K., Jones, A., Galbraith, J., Peacock, R., Nandi, U., Wachs, T., Matthay, M., Liu, K., Kangelaris, K., Wang, R., Calfee, C., Yee, K., Hendey, G., Chang, S., Lim, G., Qadir, N., Tam, A., Beutler, R., Levitt, J., Wilson, J., Rogers, A., Vojnik, R., Roque, J., Albertson, T., Chenoweth, J., Adams, J., Pearson, S., Juarez, M., Almasri, E., Fayed, M., Hughes, A., Hillard, S., Huebinger, R., Wang, H., Vidales, E., Patel, B., Ginde, A., Moss, M., Baduashvili, A., McKeehan, J., Finck, L., Higgins, C., Howell, M., Douglas, I., Haukoos, J., Hiller, T., Lyle, C., Cupelo, A., Caruso, E., Camacho, C., Gravitz, S., Finigan, J., Griesmer, C., Park, P., Hyzy, R., Nelson, K., McDonough, K., Olbrich, N., Williams, M., Kapoor, R., Nash, J., Willig, M., Ford, H., Gardner-Gray, J., Ramesh, M., Moses, M., Ng Gong, M., Aboodi, M., Asghar, A., Amosu, O., Torres, M., Kaur, S., Chen, J.-T., Hope, A., Lopez, B., Rosales, K., Young You, J., Mosier, J., Hypes, C., Natt, B., Borg, B., Salvagio Campbell, E., Hite, R. D., Hudock, K., Cresie, A., Alhasan, F., Gomez-Arroyo, J., Duggal, A., Mehkri, O., Hastings, A., Sahoo, D., Abi Fadel, F., Gole, S., Shaner, V., Wimer, A., Meli, Y., King, A., Terndrup, T., Exline, M., Pannu, S., Robart, E., Karow, S., Hough, C., Robinson, B., Johnson, N., Henning, D., Campo, M., Gundel, S., Seghal, S., Katsandres, S., Dean, S., Khan, A., Krol, O., Jouzestani, M., Huynh, P., Weissman, A., Yealy, D., Scholl, D., Adams, P., McVerry, B., Huang, D., Angus, D., Schooler, J., Moore, S., Files, C., Miller, C., Gibbs, K., LaRose, M., Flores, L., Koehler, L., Morse, C., Sanders, J., Langford, C., Nanney, K., MdalaGausi, M., Yeboah, P., Morris, P., Sturgill, J., Seif, S., Cassity, E., Dhar, S., de Wit, M., Mason, J., Goodwin, A., Hall, G., Grady, A., Chamberlain, A., Brown, S., Bledsoe, J., Leither, L., Peltan, I., Starr, N., Fergus, M., Aston, V., Montgomery, Q., Smith, R., Merrill, M., Brown, K., Armbruster, B., Harris, E., Middleton, E., Paine, R., Johnson, S., Barrios, M., Eppensteiner, J., Limkakeng, A., McGowan, L., Porter, T., Bouffler, A., Leahy, J. C., deBoisblanc, B., Lammi, M., Happel, K., Lauto, P., Self, W., Casey, J., Semler, M., Collins, S., Harrell, F., Lindsell, C., Rice, T., Stubblefield, W., Gray, C., Johnson, J., Roth, M., Hays, M., Torr, D., Zakaria, A., Schoenfeld, D., Thompson, T., Hayden, D., Ringwood, N., Oldmixon, C., Ulysse, C., Morse, R., Muzikansky, A., Fitzgerald, L., Whitaker, S., Lagakos, A., Brower, R., Reineck, L., Aggarwal, N., Bienstock, K., Freemer, M., Maclawiw, M., Weinmann, G., Morrison, L., Gillespie, M., Kryscio, R., Brodie, D., Zareba, W., Rompalo, A., Boeckh, M., Parsons, P., Christie, J., Hall, J., Horton, N., Zoloth, L., Dickert, N., Diercks, D., and National Heart, Lung, and Blood Institute PETAL Clinical Trials Network (2020), “Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial,” JAMA, 324, 2165–2176. DOI: 10.1001/jama.2020.22240.
   PubMed Web of Science ®Google Scholar
• Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., Wang, F., Li, D., Yang, M., Xing, L., Wei, J., Xiao, H., Yang, Y., Qu, J., Qing, L., Chen, L., Xu, Z., Peng, L., Li, Y., Zheng, H., Chen, F., Huang, K., Jiang, Y., Liu, D., Zhang, Z., Liu, Y., and Liu, L. (2020), “Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma,” JAMA, 323, 1582–1589. DOI: 10.1001/jama.2020.4783.
   PubMed Web of Science ®Google Scholar
• Skipper, C. P., Pastick, K. A., Engen, N. W., Bangdiwala, A. S., Abassi, M., Lofgren, S. M., Williams, D. A., Okafor, E. C., Pullen, M. F., Nicol, M. R., Nascene, A. A., Hullsiek, K. H., Cheng, M. P., Luke, D., Lother, S. A., MacKenzie, L. J., Drobot, G., Kelly, L. E., Schwartz, I. S., Zarychanski, R., McDonald, E. G., Lee, T. C., Rajasingham, R., and Boulware, D. R. (2020), “Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19,” Annals of Internal Medicine, 173, 623–631. DOI: 10.7326/M20-4207.
   PubMed Web of Science ®Google Scholar
• Sox, H. C., and Goodman, S. N. (2012), “The Methods of Comparative Effectiveness Research,” Annual Review of Public Health, 33, 425–445. DOI: 10.1146/annurev-publhealth-031811-124610.
   PubMed Web of Science ®Google Scholar
• Suvarna, V. R. (2018), “Real World Evidence (RWE) – Are We (RWE) Ready?” Perspectives in Clinical Research, 9, 61–63. DOI: 10.4103/picr.PICR_36_18.
   PubMedGoogle Scholar
• Tang, W., Cao, Z., Han, M., Wang, Z., Chen, J., Sun, W., Wu, Y., Xiao, W., Liu, S., Chen, E., Chen, W., Wang, X., Yang, J., Lin, J., Zhao, Q., Yan, Y., Xie, Z., Li, D., Yang, Y., Liu, L., Qu, J., Ning, G., Shi, G., and Xie, Q. (2020), “Hydroxychloroquine in Patients with Mainly Mild to Moderate Coronavirus Disease 2019: Open Label, Randomised Controlled Trial,” BMJ, 369, m1849. DOI: 10.1136/bmj.m1849.
   PubMed Web of Science ®Google Scholar
• The Center For Disease Dynamics, Economics & Policy (2021), available at https://cddep.org/research-area/covid-19/. Accessed October 21, 2021.
   Google Scholar
• The RECOVERY Collaborative Group (2020), “Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19,” New England Journal of Medicine, 383, 2030–2040.
   PubMed Web of Science ®Google Scholar
• Tseng, K., Frost, I., Kapoor, G., Sriram, A., Nandi, A., and Laxminarayan, R. (2021), “Covid-19 India: State-Level Estimates of Hospitalization Needs,” available at https://cddep.org/wp-content/uploads/2020/04/Covid.state/_.hosp/_2Apr2020-3-1.pdf. Accessed October 21, 2021.
   Google Scholar
• US FDA 21st Century Cures Act (2016), available at https://www.congress.gov/114/plaws/publ255/PLAW-114publ255.pdf. Public Law 114-255: December 13, 2016. Accessed October 21, 2021.
   Google Scholar
• US Food & Drug Administration (FDA) (2020), “Coronavirus (COVID-19) Update: Daily Roundup March 30,” available at https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-daily-roundup-march-30-2020{/#}:/textasciitilde:text=On{/%}20March{/%}2028{/%}2C{/%}202020{/%}2C{/%}20the,hospitalized{/%}20patients{/%}20with{/%}20COVID{/%}2D19. Accessed October 21, 2021.
   Google Scholar
• US Food & Drug Administration (FDA) (2020), “Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine,” June 15, 2020. available at https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and. Accessed October 21, 2021.
   Google Scholar
• US Food & Drug Administration (FDA) (2021), “FDA In Brief: FDA Updates Emergency Use Authorization for COVID-19 Convalescent Plasma to Reflect New Data. February 4, 2021, available at https://www.fda.gov/news-events/fda-brief/fda-brief-fda-updates-emergency-use-authorization-covid-19-convalescent-plasma-reflect-new-data. Accessed October 21, 2021.
   Google Scholar
• Verdonk, C., Verdonk, F., and Dreyfus, G. (2020), “How Machine Learning Could be Used in Clinical Practice During an Epidemic,” Critical Care, 24, 265. DOI: 10.1186/s13054-020-02962-y.
   PubMed Web of Science ®Google Scholar
• Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., et al. (2020), “Estimates of the Severity of Coronavirus Disease 2019: A Model-Based Analysis,” Lancet Infectious Diseases, 20, 669–677. DOI: 10.1016/S1473-3099(20)30243-7.
   PubMed Web of Science ®Google Scholar
• Wang, Q., Xie, S., Wang, Y., and Zeng, D. (2020), “Survival-Convolution Models for Predicting COVID-19 Cases and Assessing Effects of Mitigation Strategies,” Frontiers in Public Health, 8, 325. DOI: 10.3389/fpubh.2020.00325.
   PubMed Web of Science ®Google Scholar
• WHO Solidarity Trial Consortium (2021), “Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial,” New England Journal of Medicine., 384, 497–511.
   PubMed Web of Science ®Google Scholar
• Wiens, J., and Shenoy, E. S. (2018), “Machine Learning for Healthcare: On the Verge of a Major Shift in Healthcare Epidemiology,” Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 66, 149–153. DOI: 10.1093/cid/cix731.
   PubMed Web of Science ®Google Scholar
• Williamson, E., Morley, R., Lucas, A., and Carpenter, J. (2012), “Propensity Scores: From Naive Enthusiasm to Intuitive Understanding,” Statis- tical Methods in Medical Research, 21, 273–293. DOI: 10.1177/0962280210394483.
   PubMed Web of Science ®Google Scholar
• Winship, C., and Morgan, S. (2014), Counterfactuals and Causal Inference: Methods and Principles for Social Research (2nd ed). Cambridge: Cambridge University Press.
   Google Scholar
• World Health Organization (WHO) Archived: WHO Timeline – COVID-19 (2021), available at https://www.who.int/news-room/detail/27-04-2020-who-timeline–-covid-19. Accessed Ocobert 21, 2021.
   Google Scholar
• Zeng, Q.-L., Yu, Z.-J., Gou, J.-J., Li, G.-M., Ma, S.-H., Zhang, G.-F., Xu, J.-H., Lin, W.-B., Cui, G.-L., Zhang, M.-M., Li, C., Wang, Z.-S., Zhang, Z.-H., and Liu, Z.-S. (2020), “Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in COVID-19 Patients,” The Journal of Infectious Diseases, 222, 38–43. DOI: 10.1093/infdis/jiaa228.
   PubMed Web of Science ®Google Scholar
• Zhang, B., Liu, S., Tan, T., Huang, W., Dong, Y., Chen, L., Chen, Q., Zhang, L., Zhong, Q., Zhang, X., Zou, Y., and Zhang, S. (2020), “Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection,” Chest, 158, e9–e13. DOI: 10.1016/j.chest.2020.03.039.
   PubMed Web of Science ®Google Scholar
• Zhao, S., and Chen, H. (2020), “Modeling the Epidemic Dynamics and Control of COVID-19 Outbreak in China,” Quantitative Biology, 8, 11–19. DOI: 10.1007/s40484-020-0199-0.
   PubMedGoogle Scholar